Free tool
FAERS Monitor: Protonix
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020987 or its brand name (Protonix, Pantoprazole Sodium). Reports on generic versions are filed under their own applications.
Reports
150,008
Serious
116,369
78% of reports
Hospitalization
53,346
Death reported
16,699
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- chronic kidney disease24,473
- acute kidney injury13,898
- fatigue11,669
- renal failure10,884
- nausea10,751
- pain10,043
- dyspnoea9,794
- diarrhoea9,645
- drug ineffective9,026
- headache8,494
- off label use8,235
- end stage renal disease7,567
- vomiting7,097
- arthralgia7,044
- asthenia6,489
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,677 |
| 2005 | 2,530 |
| 2006 | 2,944 |
| 2007 | 2,609 |
| 2008 | 2,827 |
| 2009 | 3,147 |
| 2010 | 3,759 |
| 2011 | 3,562 |
| 2012 | 4,313 |
| 2013 | 3,291 |
| 2014 | 3,732 |
| 2015 | 5,932 |
| 2016 | 5,965 |
| 2017 | 5,590 |
| 2018 | 18,754 |
| 2019 | 16,519 |
| 2020 | 7,908 |
| 2021 | 8,696 |
| 2022 | 10,518 |
| 2023 | 8,441 |
| 2024 | 9,866 |
| 2025 | 10,012 |
| 2026 | 7,414 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,904,151 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| end stage renal diseaseSignal | 7,567 | 98.6 | 95.8 | 428,553 |
| chronic kidney diseaseSignal | 24,473 | 66.1 | 65.2 | 1,068,225 |
| acute kidney injurySignal | 13,898 | 13.9 | 13.7 | 152,443 |
| renal failureSignal | 10,884 | 12.4 | 12.2 | 105,661 |
| dyspnoeaSignal | 9,794 | 2.5 | 2.4 | 8,494 |
| astheniaSignal | 6,489 | 2.4 | 2.4 | 5,542 |
| arthralgiaSignal | 7,044 | 2.4 | 2.3 | 5,762 |
| painSignal | 10,043 | 2.3 | 2.3 | 7,590 |
| vomitingSignal | 7,097 | 2.1 | 2.1 | 4,305 |
| fatigueSignal | 11,669 | 2.1 | 2.1 | 7,045 |
| diarrhoeaSignal | 9,645 | 2.1 | 2.1 | 5,735 |
| nausea | 10,751 | 1.9 | 1.9 | 4,833 |
| headache | 8,494 | 1.9 | 1.9 | 3,756 |
| off label use | 8,235 | 1.3 | 1.3 | 666 |
| drug ineffective | 9,026 | 1.0 | 0.9 | 16 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.